• Advancing Translational Immunotoxicology: Strategic ROS Assa

  2026-05-19

  Explore how advanced ROS detection—anchored by the APExBIO Reactive Oxygen Species (ROS) Assay Kit (DHE)—enables translational researchers to unravel redox-driven immunotoxicity mechanisms and design targeted interventions. Drawing on mechanistic insights, recent immunotoxicology findings, and best-practice workflows, this thought-leadership article delivers actionable guidance that bridges molecular discovery and preclinical application.

• STAT5B Overexpression Restores Myelin in Parkinson’s Models

  2026-05-18

  Li et al. (2025) reveal that oligodendrocyte-specific STAT5B overexpression mitigates myelin impairment and dopaminergic neuron loss in Parkinson’s disease (PD) models. This work uncovers a key epigenetic axis—DNMT3A-STAT5B-MBP—linking methylation-driven transcriptional repression to PD-associated myelin pathology, with broad implications for neurodegeneration research.

• Toremifene vs Tamoxifen in Advanced Breast Cancer: Evidence

  2026-05-18

  This Cochrane meta-analysis rigorously compares the efficacy and safety of toremifene and tamoxifen for advanced breast cancer. The review finds similar clinical outcomes between the two selective estrogen receptor modulators, informing therapeutic decision-making in hormone receptor-positive disease.

• TCF25 Orchestrates Lysosomal Cell Death Under Glucose Starva

  2026-05-17

  Ren et al. (2025) identify TCF25 as a critical nutrient sensor that modulates lysosomal acidification and triggers cell death via ferritinophagy in glucose-starved cells. These findings clarify the molecular link between metabolic adaptation and lysosome-dependent cell death, suggesting new avenues for targeting metabolic vulnerabilities in disease.

• Trelagliptin Succinate: Integrative Pathways in Diabetes and

  2026-05-16

  Explore the multifaceted scientific profile of Trelagliptin succinate—a selective DPP-4 inhibitor—examining its advanced mechanisms and unique potential in both type 2 diabetes and bone biology research. This article delivers a deeper, integrative analysis distinct from existing reviews.

• Oteseconazole (VT-1161): Applied Workflows for Candida Resea

  2026-05-15

  Oteseconazole (VT-1161) enables high-precision Candida susceptibility assays even in the face of fluconazole resistance and complex drug-drug interaction profiles. This article delivers step-by-step protocols, troubleshooting strategies, and translational insights to unlock the compound’s full potential in antifungal research and clinical modeling.

• hiPSC-Derived Intestinal Organoids for Human Pharmacokinetic

  2026-05-15

  This study presents a streamlined protocol to generate intestinal organoids from human pluripotent stem cells, offering a physiologically relevant in vitro model for pharmacokinetic investigations. The model addresses limitations of previous systems by supporting maturation and functional drug metabolism, enhancing translational relevance for gastrointestinal drug research.

• Oteseconazole (VT-1161): Advanced Antifungal Assay Strategie

  2026-05-14

  Oteseconazole (VT-1161) delivers potent, selective inhibition of Candida growth and stands out for its low risk of drug-drug interactions, enabling robust antifungal workflows. This article guides researchers in experimental design, troubleshooting, and maximizing data quality using Oteseconazole from APExBIO.

• Evaluating Low-Cost Microfluidic Mixers for LNP-mRNA Product

  2026-05-14

  This study systematically assesses low-cost microfluidic mixers and manual pipette mixing for producing lipid nanoparticles (LNPs) encapsulating mRNA, comparing physical properties and expression outcomes. The findings validate the suitability of budget-friendly microfluidic devices for bench-scale and high-throughput LNP-mRNA research, supporting broader accessibility and reproducibility in gene delivery studies.

• Dynasore: Applied Protocols for Dynamin GTPase Inhibition

  2026-05-13

  Dynasore empowers precise and reversible modulation of dynamin-dependent endocytosis, making it a gold-standard tool for dissecting vesicle trafficking and pathogen entry mechanisms. This article unpacks workflow optimizations, experimental troubleshooting, and evidence-driven guidance for leveraging Dynasore in cellular and infection models.

• Cisplatin (SKU A8321): Reliable Solutions for Lab Assays

  2026-05-13

  Navigate common pitfalls in cell viability and apoptosis workflows with evidence-driven insights on Cisplatin (SKU A8321). This scenario-based guide equips biomedical researchers and lab technicians with validated best practices and protocol parameters to improve reproducibility and interpretability in cancer research studies.

• UBR1/UBR2: Central Mammalian ER Stress Sensors and PQC Regul

  2026-05-12

  This study uncovers the pivotal roles of mammalian E3 ubiquitin ligases UBR1 and UBR2 as ER stress sensors and modulators of protein quality control (PQC). The findings reveal that these N-recognins stabilize under ER stress, helping cells adapt and survive, while their loss increases susceptibility to ER stress-induced apoptosis.

• Toremifene in Breast Cancer: Two Decades of Clinical Evidenc

  2026-05-12

  This review synthesizes 20 years of clinical data on toremifene, a selective estrogen receptor modulator (SERM), evaluating its efficacy and safety in hormone receptor-positive breast cancer. The study provides nuanced guidance on its use relative to aromatase inhibitors and highlights the importance of biomarker-driven, personalized therapy.

• Dorsomorphin (Compound C): Precision Tools for AMPK Pathway

  2026-05-11

  Dorsomorphin (Compound C) empowers researchers to dissect AMPK and BMP signaling with unmatched selectivity, fueling breakthroughs in metabolic, autophagy, and differentiation assays. This guide distills best practices for experimental setup, protocol optimization, and troubleshooting—bridging foundational insights with real-world research needs.

• Chlorambucil: Optimizing DNA Crosslinking Workflows in Cance

  2026-05-11

  Chlorambucil, a nitrogen mustard alkylating agent, enables precise DNA crosslinking strategies for apoptosis induction and cytotoxicity profiling in cancer models. This guide provides actionable, evidence-backed workflows and troubleshooting tips to maximize reproducibility and assay sensitivity with APExBIO’s high-purity Chlorambucil.

14769 records 4/985 page Previous Next 12345 下5页 Last page